Category: CannabisNewsWire Release

420 with CNW — Coalition Urges Biden Administration to End Federal Prohibition, Deschedule Marijuana

A coalition made up of more than 80 groups recently penned  a letter to President Joseph Biden asking that he put an end to the federal prohibition of cannabis.  In the letter, the coalition stated that too many lives had been affected by the country’s failed approach to marijuana and urged that the administration support comprehensive cannabis reform bills in Congress.

This includes measures such as the Cannabis Administration and Opportunity Act. which deschedules cannabis, establishes a regulatory framework for marijuana markets and repairs the past harms of prohibition.

Marijuana criminalization has led to the unfair targeting of Black, Indigenous and other people of color, despite the fact that the drug’s use is roughly equal among whites and Blacks.

Late last year, the president issued a proclamation pardoning individuals with simple marijuana possession offenses at the federal level. While this did help a few, the majority of those affected by federal criminalization of cannabis weren’t granted relief. This is mainly because federal sentencing usually jails individuals for higher-level offenses that are more complicated than simple possession.

Removing marijuana completely from Schedule 1 of the Controlled Substances Act instead of classifying it in a lower schedule would not only bring the cannabis industry into compliance with existing federal laws and regulations but also reduce sentences, stop future arrests and offer a pathway for resentencing.

Descheduling would also afford workers in state-legal cannabis industries the protections of the Fair Labor Standards Act and the National Labor Relations Act, which are available to workers in other industries. This is in addition to eliminating the regulatory barriers that prevent research on marijuana from advancing.  Furthermore, veterans would be allowed access to medical cannabis programs through their VA physicians.

The coalition noted that while descheduling marijuana and other administrative actions would greatly advance criminal justice reform efforts, a comprehensive regulatory framework was needed to ensure no parties involved in the industry were affected.

In the letter, advocates added that other actions that could end the current harms of cannabis prohibition included reducing the harms of state law convictions that make up majority of low-level cannabis convictions in the country. The letter also encourages that the White House work with Congress to approve comprehensive descheduling bills that include repairing and centering communities most harmed by criminalization and prohibition, criminal justice reform, and a regulatory framework rooted in justice, equity and public health.

Organizations involved include the Second Chance Clemency Project, Marijuana Policy Project, Minorities for Medical Marijuana, Students for Sensible Drug Policy and VOCAL-WA, among many others.

The calls for reform, if heeded, could have a beneficial effect on the operations of companies such as IGC Pharma Inc. (NYSE American: IGC) since there would be fewer hoops to navigate as studies or different needed manufacturing processes are undertaken.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Pennsylvania Bill Seeks to Let Nurses Administer Medical Cannabis to Students

Representative Malcolm Kenyatta of Pennsylvania’s state legislature says he intends to introduce a measure that allows school nurses to give medical cannabis to students. According to the state’s health department, the administration of medical cannabis to students with severe medical conditions under a Patient Authorization Letter is supported by both the departments of health and education, as long as a safe environment is maintained for all students while on school premises.

The current guidelines state that:

  • Parents, caregivers or legal guardians may deliver medical marijuana to their children or students on school grounds if they provide a copy of the patient authorization letter to the principal of the school and notify the principal of the school in advance of each time the caregiver or parent will administer medical cannabis to the student.
  • The school administrator must also notify the school nurse as well in each case where the parent or caregiver will be administering the drug to the student.
  • The parent or caregiver must adhere to all school policies that apply to people visiting the school during learning hours.
  • A parent or caregiver must bring the medical cannabis to the school and give it to their child without causing a distraction. They must also remove any leftover medical cannabis and associated materials from the school’s property once they finish administering the drug.
  • The learning institution should provide a safe, private space for the parent to administer the drug to the student.
  • Medical marijuana of any kind must not be in the possession of students themselves at any time while on school grounds or while participating in any school-related activities.

The suggested guidelines will be in place until the state’s education department issues rules governing the use and possession of medical marijuana in the state’s educational institutions.

A school nurse might deliver medical marijuana to a child under Kenyatta’s proposed legislation if they are qualified to do so as a secondary caregiver. Additionally, the bill would exclude school nurses from the $50 caregiver charge. Kenyatta expressed his hope that his legislation would make it simpler for kids to access life-improving medication while they were in school.

Pennsylvania established the medical cannabis program in April 2016 to offer access to patients with significant medical conditions through a secure and efficient means of delivery that combines patients’ demand for access to the most recent medicines with patient care and safety.

Growing marijuana markets such as the one in Pennsylvania hold promise for not only direct players in the marijuana industry but also other associated enterprises such as Advanced Container Technologies Inc. (OTC: ACTX), which see a market in providing what marijuana-touching entities need to run their operations.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New Jersey’s Marijuana Market Still Facing Issues Following Launch

One year ago, the state of New Jersey launched its recreational marijuana sales. This was more than a year after voters approved a measure to legalize cannabis, which meant that consumers could finally buy edibles, vapes and marijuana legally at specific dispensaries.

This was just on paper, however. It actually took the government months to begin accepting and approving applications for cannabis retailers. At the moment, the state has 24 recreational dispensaries, all of which are run by multistate operators that had first received approval to sell medical marijuana.

The state has also awarded more than 1,200 conditional licenses to grow, manufacture and retail marijuana with roughly 100 yearly licenses also being awarded.

This doesn’t meet the expectations of many who thought more shops would be open by now and that there would be better access to capital. Despite this, significant strides have been made since the market’s inception.

For instance, more than $328 million in recreational marijuana products was sold from April 21, 2022, to December 31, 2022, with the state collecting more than $20 million in tax.

The state also focused on social equity through its CREAMM Act, which allows individuals in communities that were affected by the war on drugs to reap the benefits of marijuana legalization.  It is also trying to prioritize women, minority and veteran-owned businesses, with roughly 70% of all licenses being awarded to businesses with diverse ownership.

New Jersey still has issues to fix, however, with the primary one being slow approvals for licenses.

One legislator is planning to introduce a measure that would assign the task of regulating the marijuana market to a state department. Sen. Vin Gopal acknowledged that the cannabis regulatory commission needed oversight and accountability, adding that the challenges arising needed to be dealt with.

Senate President Nicholas Scutari, who championed for cannabis legalization, added that the time had come to evaluate the work the commission had done. He then noted that he was focused on making the process less taxing for applicants. In addition to this, he revealed that proposals had been made to permit home growing of cannabis.

Dianna Houenou, chair of the Cannabis Regulatory Commission, highlighted that while she did sympathize with business owners, some issues, such as struggling to secure capital funding, applications missing documents, municipalities hostile to legal marijuana and supply chain issues, weren’t in the commission’s control.

Nearly 70% of towns in the state have chosen not to permit marijuana businesses to open within their borders.

When enterprises such as IGC Pharma Inc. (NYSE American: IGC) eventually take their cannabis-based medicinal formulations successfully through the drug-development process and win FDA approval, no such restrictions will be imposed by different states or cities regarding where they can or cannot be sold to patients as long as the drugs are in conformity with federal medicine laws.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Delaware Governor Lets Cannabis Bills Become Law Sans His Signature

Delaware Governor John Carney stated that he would permit two bills to become law without his signature to legalize cannabis possession and create a controlled adult-use market. This has since come to pass.

Advocates were worried that the governor would override the proposals, as he did during the previous session. He did, however, recently announced that he would let HB 1 and HB 2 take effect without his active participation, which came as a happy surprise to supporters.

Carney, who had previously refrained from commenting on his intentions regarding the marijuana reform proposals from Representative Ed Osienski (D), said that while his opinions on the matter have not changed and he continues to believe that legalizing marijuana is not a positive move, he would no longer oppose the reform.

In a similar vein, he stated during a town hall meeting last week that he thought it was time to put the discussion of marijuana to rest and concentrate on other matters after being challenged on the subject by a number of attendees. In his most recent address, he underlined his unresolved reservations and reiterated the point he had made earlier, outlining the reasons why he would permit the proposed legislations to become law, albeit symbolically and without his signature.

The following is what the legalization measure, HB 1, will achieve:

  • A change to state law would make it lawful for adults aged 21 years and above to possess, use, share and buy up to an ounce of marijuana.
  • To prevent misuse of the gifting clause, the law specifies that adult sharing does not include giving away cannabis concurrently with another reciprocal transaction between the same people.
  • Consumption of cannabis in public and its cultivation remain illegal.
  • A civil fine of up to $100 could be imposed for a first violation on those who use or possess cannabis if they are under age 21. However, police might exercise discretion and cite someone instead of charging that fee.

Here is a summary of the main clauses in the HB 2 regulation bill:

  • The measure would offer a fundamental basis for establishing a regulated adult-use marijuana trade system.
  • The Division of Alcohol and Tobacco Enforcement, through a newly created Office of Cannabis Control Commissioner, would be in charge of overseeing the market.
  • Only a maximum of 30 marijuana retail licenses could be granted by regulators during the first 16 months of operation.
  • The license scoring procedure would give priority to applicants who can demonstrate that they would hire people from diverse backgrounds and offer a livable wage, health insurance, paid time off for illness, and sick leave.
  • The Justice Reinvestment Fund, which supports restorative justice, employment development, technical help for those who are economically disadvantaged and more, would receive 7% of the money collected from cannabis revenue.
  • Recreational cannabis sales would be subject to a 15% sales tax. There would be no tax on medical marijuana products.

The newly enacted cannabis legalization laws could potentially create a market for businesses such as Advanced Container Technologies Inc. (OTC: ACTX), which supply indoor cultivation equipment to marijuana growers at commercial scale.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Successful DIAB-A22-1 Diabetes Study Indicates Just One of Several Potential Applications for DehydraTECH(TM) Drug Delivery Platform Technology

  • Lexaria recently completed its diabetes animal model study, DIAB-A22-1, an ambitious study that explored the potential of its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for the treatment of diabetes
  • The study showed at least three primary positive outcomes, including weight loss and improved triglyceride and cholesterol levels, with lower doses of DehydraTECH-CBD achieving the most optimum outcome
  • The success of this study inches Lexaria closer to capitalizing on the potential of the diabetes drug market, estimated at $63.1 billion in 2021
  • It also points to the technology’s effectiveness, particularly following the success of the company’s most ambitious clinical study, HYPER-H21-4, demonstrating the potential of DehydraTECH-CBD for the treatment of hypertension

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms. The company’s patented DehydraTECH(TM) drug delivery platform technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of active pharmaceutical ingredients. They recently completed its diabetes animal model study DIAB-A22-1, an ambitious study that explored the potential of its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for the treatment of diabetes. The study produced at least three positive outcomes in what Lexaria’s management described as “encouraging,” further indicating many prospective benefits worthy of further investigation together down the line (https://cnw.fm/fw4H8).

The study, which involved 32 male Zucker (“ZDF”) rats- 24 obese and eight lean, saw the administration of Lexaria’s “DehydraTECH-CBD 2.0” formulations at either 30 mg/Kg or 100 mg/Kg of body weight. Following initial positive early responses witnessed, the study, which was to last for four weeks, was extended to eight, with outcomes including weight loss in obese diabetic-conditioned animals, to improved triglyceride and cholesterol levels.

Across all three parameters, only the lower dose of DehydraTECH-CBD achieved the most optimum outcome, with higher doses showing no significant difference. With activity levels, for instance, lower DehydraTECH-CBD doses resulted in a statistically significant improvement in locomotor activity compared to the untreated obese control rats, with no significant difference accordingly evidenced at the higher dose. Furthermore, a lower dose of 30 mg/Kg also outperformed the higher dose of 100 mg/Kg with reductions in triglyceride levels from day 35 onwards compared to the obese animals not dosed with DehydraTECH-CBD.

No severe health concerns were observed during dosing in the animals that received DehydraTECH-CBD. Lexaria’s management was keen to express its pleasure that relatively low doses of DehydraTECH-CBD seemed to support tangible improvements in the day-to-day health of the lab animals. This showed how essential the findings are for many other prospective benefits worthy of further investigation, perhaps with other drugs that further help control glucose levels directly.

Lexaria’s unique and powerful drug delivery technology, DehydraTECH, has proven to enhance the performance of several categories of fat-soluble molecules and drugs across oral and/or topical product formats. As a result, it is an additional step easily incorporated into the formulation and manufacturing process of existing or new orally ingestible and topical products. This feature has been applied in antiviral drugs, cannabinoids, oral nicotine, PDE5 inhibitors, and more. The technology’s potential has also opened up Lexaria’s licensing opportunities, particularly given the technology’s suitability for use with a growing range of consumer products such as registered drugs, nutraceuticals, oral suspensions, capsules, pills and tablets (https://cnw.fm/JGDhQ).

The success of the DIAB-A22-1 animal model study inches Lexaria closer to capitalizing on the potential of the diabetes drug market, estimated at $63.1 billion in 2021 (https://cnw.fm/Pz8oK). It also points to the technology’s effectiveness, particularly following the success of Lexaria’s most ambitious human clinical study, HYPER-H21-4, demonstrating the potential of DehydraTECH-CBD for treating hypertension. This success also aligns with the company’s objective of delivering financial rewards to its shareholders, all while proving the validity of its technology.

“it is my goal for 2023 to make Lexaria Bioscience one of the top drug delivery performers in the biotech/pharmaceutical world as we continue to prove the validity of our technology, and really begin our efforts to deliver financial rewards to you, our owners,” noted Chris Bunka, Lexaria’s CEO (https://cnw.fm/0UGmb).

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Research Finds Marijuana Gives Roundworms the Munchies

New research has found that roundworms exposed to marijuana compounds also get the munchies, just like humans. Cannabinoid molecules derived from the marijuana plant usually bind to endocannabinoids, whose receptors are found in the brain, other organs and connective tissues.

Popular cannabinoid molecules include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG), 9-tetrahydrocannabivarin (THCV), cannabidivarin (CBDV) and cannabivarin (CBV).

The endocannabinoid system is said to balance key bodily functions and regulate functions such as eating, anxiety, memory and sleep.

Researchers found that roundworms, or Caenorhabditis elegans as they are scientifically referred to as, fed for longer than normal while under the influence of marijuana. The worms also demonstrated a higher preference for high-quality foods over less nutritious foods.

The research suggests that the mechanism by which marijuana impacts appetite evolved more than 500 million years ago, when the evolutionary paths of humans and C. elegans diverged. This mutuality across the animal kingdom suggests that these worms could be used to study how marijuana affected the nervous system in humans.

Shawn Lockery, lead author of the study and a neuroscientist at the University of Oregon-Eugene, stated that better understanding basic drug physiology would directly influence societal health as a whole.

The researchers were motivated to conduct the experiments after the state of Oregon legalized adult-use marijuana. For their study, the scientists divided the worms into two groups then submerged one group in a solution of the endocannabinoid anandamide before placing them in the maze.

They observed that the worms developed bigger appetites, noting that in the maze, these worms mainly preferred higher quality foods, in addition to spending more time eating.  Roundworms that were plunged in the solution also demonstrated less interest in bacteria that was nutritionally inferior, with researchers noting that these effects were pronounced in worms with working endocannabinoid receptors.

In separate experiments, the scientists tested endocannabinoids on worms with genetically engineered human cannabinoid receptors.

They observed that the worms responded in a similar way, with the scientists highlighting that the cannabinoids affected the worms’ food-detecting olfactory neurons, making them more sensitive to the odors of preferred bacteria.

Prior studies have demonstrated that cannabinoids cause hedonic hunger in other mammals such as primates and rats.

This latest research calls attention to similarities suggesting that Caenorhabditis elegans could offer a cost-effective way to model how compounds derived from marijuana affect the nervous system in humans.

The study reported its findings in the “Current Biology1” journal.

Plenty of research is currently ongoing, with enterprises such as IGC Pharma Inc. (NYSE American: IGC) setting their sights on having FDA-approved formulations on the market to help patients with different ailments.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Could Interstate Commerce Fix Cannabis Glut in Legal States

Despite there being a huge supply of cannabis thanks to excellent growing conditions and lot of expertise and knowledge, any extra product is legally restricted to each state’s borders because of the federally sanctioned use of marijuana. However, It’s an open truth that some licensed farmers have sent goods to the out-of-state illicit market to stay afloat in Oregon. The state’s top cannabis regulator recently issued a warning about an existential crisis in the marijuana business.

Most cannabis companies in California are struggling with millions of dollars in outstanding debts, and some have had to shut down their cultivation operations. On the West Coast, producers deal with what many refer to as the disastrous economics of legal marijuana.

Nobody in the sector believes that a divided Congress will step in to help by legalizing the substance, enabling marijuana businesses to deduct expenses, or even just loosening banking prohibitions that usually prevent them from accessing loans or credit. Instead, some people are placing their bleakest hopes — and dreams — in the presidency of Joe Biden, which they believe will open the door to marijuana trading across states that have authorized the drug’s use. As a result, they contend, the West Coast might assist in supplying the rest of the nation thanks to its hospitable climate and clean, inexpensive hydropower for indoor cultivation.

According to Attorney General Merrick Garland’s testimony before the Senate last month, the Justice Department will soon announce a new marijuana policy that will largely follow the “Cole Memorandum” of 2013, which stated that as long as specific legal priorities were met, the federal government would not intervene in state marijuana regulation initiatives.

Experts on drug policy predict that the new approach won’t go as far as allowing interstate trade.

However, lawmakers in Washington State enacted a “trigger bill” last week that gives the governor the power to enter into interstate marijuana commerce agreements should the federal government permit it. This legislation was fashioned after similar measures that have already been passed in California and Oregon.

A state’s market structure has an impact on how its industries are currently performing as well as how they might perform should enterprises be permitted to sell outside of the state.

Colorado and Washington were the first to legalize recreational cannabis in 2012. Many of the early laws Washington passed to fend off the Justice Department, such as those limiting the size of expanding facilities and prohibiting out-of-state investment, are still in effect.

Some smaller producers have prospered as a result. However, legislation might impede those looking to compete across state borders with bigger, more effective producers from California and Oregon, who operate with fewer restrictions. Large producers in Oregon have attained certain economies of scale that may offer them an advantage in a larger market. However, the state’s overstock is currently regarded as the worst in the country.

The opening of interstate commerce involving marijuana would open up interesting possibilities for entities which are in the business of providing supplies to cannabis industry actors, such as Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lift Toronto 2023 Promises to Drive Meaningful Change and Sustainable Growth in Cannabis Industry while Providing Memorable Experiences

Lift Events & Experiences, a collective known for organizing Canada’s number-one cannabis industry conferences and trade shows, invites cannabis retailers, licensed producers, growers, budtenders, brands, investors, and everyday folks, for the Lift Toronto 2023 event scheduled for June 1-3, 2023 at the Metro Toronto Convention Centre (“MTCC”). The three-day action-packed convention is set to continue a tradition that has become synonymous with each of Lift Events & Experiences’ events: showcasing leading-edge content and premier exhibitors in a high-energy, unique setting.

The first day of the event will play host to the Lift Cannabis Business Conference, Canada’s premiere business strategy gathering that congregates regulators, researchers, top leaders, investors, suppliers, and various professionals with the intention of enabling them to learn, network, and chart a path forward for the budding cannabis industry.

The speakers will share their insights as part of planned speeches, panel discussions, and presentations, segmented into themed sessions designed to collectively spark conversations that support meaningful change and sustainable growth in the cannabis industry both in Canada and around the world. The day will kick off with a keynote addressing Canada’s cannabis industry, highlighting that October will mark five years of cannabis legalization in the North American country.

The first session, titled The CEO’s Perspective, will tackle the question of whether the future of the cannabis industry is bullish or bearish from their perspective as leaders in the space. The panel will include Niel Marotta, CEO and Founder of INDIVA, David Schwede, CEO Heritage Cannabis, Marcie Kiziak, CEO Nova Cannabis, and John Fowler, CEO Muskoka Grown & Dank Craft.

Other sessions held throughout the day will include the International Review, which will provide a deep-dive into the international cannabis industry; Truth to Power Presentations, a session looking at the cannabis industry from a legal and tax perspective; the Business Funding session; Extracts, Concentrates, & Processing session with discussions around cannabis products and manufacturing. The conference concludes with sessions around marketing and retail, Cannabis Marketing and Cannabis Retail (https://cnw.fm/kH5nq).

The heavily attended Lift Expo on June 2-3, will then connect hundreds of companies from the entire cannabis ecosystem set to exhibit their products and services. In addition to getting to know about these companies, the two high-energy Lift Expo days will also be opportune for attendees to network with peers, experts, producers, retailers, and more.

Attendees will hear from respected leaders in the space, including founders and CEOs of licensed cannabis producers, growers, and brands from different parts of the world. From the Main Stage, or Speakers’ Corner East and West Stages, attendees will find the most innovative, game-changing, and profitmaking content showcased over the two days of unmatched professional, consumer, recreational and medical cannabis programming. Everyone in attendance is invited to join Canada’s top cannabis chefs for live demonstrations of out-of-this-world cookery, baking, mixology and munchie-making, at the first-ever Lift exclusive Diners’ Club!

As has become the norm for all Lift Events & Experiences events, attendees should expect the unexpected, as the organizer promises its signature surprises and ‘a-ha’ moments. Attendees can also expect prize giveaways, live music, and cameo appearances, not to mention a legendary official after-party set for the evening of June 3.

With a commitment to lifting the cannabis community across North America, the Lift Toronto 2023 event is specifically curated to provide a uniquely irresistible experience that educates and enables attendees to create meaningful connections while driving the industry forward.

To learn more, please visit https://cnw.fm/QDfAH.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — North Carolina Legislators File Bills to Legalize Recreational Cannabis

Two measures that would end marijuana prohibition for adult use are pending in the North Carolina state legislature as lawmakers work to make the drug finally legal in their state. The first bill, HB 626, was introduced by four Democratic members of the House on Monday. If approved, the bill would make it legal for adults aged 21 years and older to possess small amounts of marijuana.

Even though the possession of less than half an ounce of cannabis was decriminalized back in 1977, it is still illegal in North Carolina and carries a punishment of up to $200. Even medical cannabis is still illegal, and the only product that people with uncontrollable epilepsy may consume legally is CBD oil with little to no THC.

According to a SurveyUSA study conducted last year, 57% of voters in the state support making cannabis legal for adults. This indicates that the public is in favor of the decision.

HB 626 would also create guidelines for the manufacture and distribution of adult recreational products. Additionally, the measure has elements of social fairness that are intended to assist areas that have suffered because of prohibition. The legislation has been sent for review to the House Committee on Calendar, Rules, and Operations.

Another measure, SB 346, was introduced on March 21, 2023, by four Democratic senators; the proposed legislation is still pending in the state’s upper house legislature. Adults would be allowed to possess a maximum of two ounces of cannabis or 15 grams of concentrates, and they would be allowed to grow up to six plants.

The bill also establishes a regulatory structure for the recreational cannabis market and establishes a new Social Equity Office that would support and encourage people from communities that have historically been disproportionately harmed by cannabis prohibition and enforcement to participate fully in the regulated cannabis industry.

Reformers point out that lifting the prohibition on marijuana can result in increased tax income for the state, in addition to the economic advantages that businesses and their employees will experience as a result. SB 346 imposes a 20% tax on cannabis-related products and grants local governments the option of levying an extra 3% tax. SB 346 is currently being discussed by the Senate Committee on Operations and Rules.

A separate bill, SB 3 (the North Carolina Compassionate Care Act), is also awaiting approval in the House. The bill passed the Senate by a 36 to 10 vote on March 1, 2023.

While these steps are being taken to legalize recreational marijuana, plenty of work is being done by entities such as IGC Pharma Inc. (NYSE American: IGC) to develop therapeutic formulations from many marijuana cannabinoids, including THC.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Retailers Celebrate 4/20 with Deals, Promotions

April 20, or 4/20 as the day is normally referred to, is an unofficial holiday celebrated by marijuana smokers across the Unites States and in other parts of the world. Marijuana retailers in America marked the day with in-store events, deals and promotions geared toward meeting their consumers’ needs and attracting new customers.

Many planned to run their promotions for a week or even a month instead of one day, which would go a long way in bringing in foot traffic.

Historically, 4/20 is a boon for marijuana retailers, with Treez CEO John Yang revealing that in 2022, the company’s aggregated sales increased by 25% during this holiday period.

Senior VP of Acreage Holdings, Kate Nelson, revealed that the company was focused on ensuring its customers had a wonderful experience during this holiday. Acreage Holdings, which operates in multiple states, had different volume-pricing opportunities daily in addition to holding giveaways every hour.

Another company, 4Front Ventures, allowed third-party vendors to hold pop-up events at its retail outlets. The company’s VP of store operations, Kristie Shaw, revealed that while the deals offered weren’t complex, they varied in each state.

Some businesses also launched new products and brands on this marijuana holiday. The Flower Shop, a vertically integrated company with operations in Utah and Arizona, launched a THC-infused seltzer dubbed High Tide; a range of marijuana products under the High Variety brand; and Ladylike, which has been designed to target female consumers. Company’s president Greta Brandt revealed that the company would be offering a promotion at its outlets that would run for 20 days to ensure expected foot traffic was accommodated.

Curaleaf Holdings, which is based in New York, has also held exclusive events and giveaways leading up to the holiday. The company recently introduced its revamped rewards program, which has more than 1.8 million members and covers 14 states. Under the program, consumers earn loyalty points that can be redeemed on future purchases at stores operated by Curaleaf.

This year’s celebration also marks three years since the start of the coronavirus pandemic, which saw many marijuana retailers adopt new ways to run their businesses and deliver products to consumers. For instance, some businesses offered drive-thru window pickups while others launched online ordering and curbside pickup.

These changes led to expansion in home-delivery networks and increased use in touchless-payment solutions, which makes it even more convenient for consumers to shop.

The marijuana industry is growing from strength to strength with each passing year, and this growth is leading to the opening up of opportunities for affiliated companies such as Advanced Container Technologies Inc. (OTC: ACTX) that don’t directly deal in marijuana but offer ancillary services and products.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.